Clinical and Molecular Challenges in Diagnosing Myeloproliferative Neoplasms with Low JAK2V617F Allelic Burden: A Single-Center Perspective and Literature Overview

Read full text Summarise with VIRAT
Authors: Erika Morsia, Dorela Lame, Michelangelo Pianelli, Ilaria Battilà, Giorgio Gramazio, Riccardo Ceccarelli, Sônia Maria Coelho Móre, Serena Rupoli, Antonella Poloni
Cited by: 0
References: 39

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background/Objectives: The increasing sensitivity of molecular diagnostic techniques has led to the frequent detection of low-level JAK2 V617F mutations in individuals without overt myeloproliferative neoplasms (MPNs), creating uncertainty regarding their biological and clinical significance. This study aimed to evaluate the clinical relevance, thrombotic risk, and hematologic evolution associated with low JAK2 V617F allele burden. Methods: We conducted a retrospective single-center study including adult patients tested for JAK2 V617F between January 2016 and December 2023. Patients with a variant allele frequency (VAF)

Fields of Study & Subjects

Myeloproliferative Neoplasms: Diagnosis and Treatment Platelet Disorders and Treatments Acute Myeloid Leukemia Research

Publication details

Journal / source
International Journal of Translational Medicine
Volume
6
Issue
2
Pages
13–13
Publication date
30 March 2026
Language
EN